Adarx has raised $321M across 2 funding rounds, plus 1 undated round. The company is valued at $827.8M.
2 funding rounds, the latest highlighted.
No date is disclosed for this round.
OrbiMed Advisors, SR One Capital Management, Lilly Asia Ventures, Sirona Capital. $46M raised, led by Ascenta Capital.
No filing has been made.
2 dated rounds, newest first.
BlackRockCCommodore CapitalCCormorant Asset ManagementHHBM Healthcare InvestmentsTTCG CrossoverIInvusMMarshall WaceRRedmile Group
T. Rowe Price
VenrockVVivo CapitalLead investors for each round are in the funding timeline.
The closest software/technology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Adarx is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
